Turkey Regulatory Update: New Health Loans, Vaccine Compensation
This article was originally published in PharmAsia News
The World Bank has allocated new funds to the Turkish healthcare system, the health ministry is to compensate a vaccination victim, and pharmacists have warned over drug shortages and called for a more realistic Euro rate. Meanwhile, a former SGK president goes to Washington and six new drugs are added to the reimbursement list.
You may also be interested in...
Turkey’s efforts to control rising rates of COVID-19 are compromising the ability of hospitals to pay their debts to medtech and pharmaceutical companies. The government has devised a payments plan, but there is catch.
The Turkish medtech industry’s ongoing hospital payments problems appeared likely to come back onto the government’s agenda, with the national economy recovering somewhat in late 2019. But COVID-19 dashed those hopes.
Growth prospects for Turkey’s medical technology market are significant, but local companies have complained about public policies that are harmful to business and about the ongoing crisis in the hospital system. Now, international medtechs are starting to react, with some downscaling local operations and portfolios. Association of Research Based Medical Technologies Manufacturers president Umut Gokalp laid out the problems being faced by industry, and what action he thinks the government should take.